Pharmaceuticals

Nucleic Acid Therapeutics Market 2026 highlighting strong growth potential driven by innovation and expanding applications through 2030

March 23, 2026March 24, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Expansion Is Predicted For The Nucleic Acid Therapeutics Market Between 2026 And 2030?

The nucleic acid therapeutics market size has shown substantial growth in recent years. It is anticipated to increase from $6.94 billion in 2025 to $8.01 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 15.4%. This historical expansion can be linked to factors such as the restricted access to nucleic acid therapeutics, a dependency on conventional small molecule treatments, an escalating demand for precision medicine, regulatory endorsements for initial gene therapies, and heightened academic investigation into gene modulation.

The nucleic acid therapeutics market size is projected for substantial expansion over the coming years, reaching $14.07 billion by 2030 with a compound annual growth rate (CAGR) of 15.1%. This anticipated growth is driven by factors such as the advancement of crispr and other gene editing technologies, wider availability of lipid nanoparticle (lnp) delivery systems, increasing uptake of personalized nucleic acid therapies, stronger partnerships between pharmaceutical and biotechnology companies, and greater investment in rna-based therapeutics. Key trends expected during this period involve the increasing use of antisense oligonucleotides (asos) and sirna therapies, further development of crispr-based and gene editing treatments, an increase in targeted therapies for neuromuscular, metabolic, and oncological conditions, enhanced investment in both non-viral and viral delivery methods, and the emergence of long non-coding rna (lncrna) and microrna (mirna) therapeutics.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27368&type=smp

What Drivers Are Influencing The Nucleic Acid Therapeutics Market?

The expanding prevalence of genetic and chronic diseases is projected to drive the growth of the nucleic acid therapeutics market. These conditions involve the connection between inherited genetic factors and the onset, progression, or risk of long-term health issues such as diabetes, cardiovascular diseases, cancer, and autoimmune disorders. The increase in such diseases is largely attributable to advancements in diagnostic technologies, enabling more accurate and earlier identification. Nucleic acid therapeutics offer a valuable approach for these conditions, as they can precisely target and modify the underlying genetic causes by regulating, repairing, or silencing specific genes, thus providing personalized treatment options. For example, in October 2024, data from the Cystic Fibrosis Trust, a UK-based charity supporting cystic fibrosis patients, indicated that registered patients rose from 11,148 in 2022 to 11,318 in 2023, marking a 1.5% year-over-year increase. Consequently, the rising incidence of genetic and chronic diseases is a significant factor propelling the nucleic acid therapeutics market.

Which Market Segments Are Examined In The Nucleic Acid Therapeutics Market Study?

The nucleic acid therapeutics market covered in this report is segmented –

1) By Therapy Type: Antisense Oligonucleotides (ASOs), Small Interfering RNA (siRNA), Gene Therapies, Aptamers, Other Therapy Types

2) By Therapeutic Area: Neuromuscular Disorder, Metabolic Disorders, Cardiovascular Disorders, Ophthalmological Disorders, Oncological Disorders, Other Therapeutic Areas

3) By Route Of Administration: Intravenous, Subcutaneous, Other Route Of Administrations

4) By Delivery Method: Viral Vector-Based Delivery Systems, Non-Viral Delivery Systems

5) By End-Use: Pharmaceutical Companies, Government And Academic Research Institutes, Biotech Companies

Subsegments:

1) By Antisense Oligonucleotides (ASOs): Phosphorothioate ASOs, 2’-O-Methyl ASOs, Locked Nucleic Acid (LNA) ASOs, Gapmer ASOs, Morpholino ASOs

2) By Small Interfering RNA (siRNA): Lipid Nanoparticle (LNP) Formulated siRNA, GalNAc-Conjugated siRNA, Chemically Modified siRNA, Naked siRNA

3) By Gene Therapies: Viral Vector-Based Gene Therapy, Non-Viral Vector-Based Gene Therapy, CRISPR-Based Gene Therapy, Zinc Finger Nucleases (ZFNs), TALENs

4) By Aptamers: Ribonucleic Acid (RNA) Aptamers, Deoxyribonucleic Acid (DNA) Aptamers, Spiegelmers, Pegylated Aptamers

5) By Others Therapy Types: MicroRNA (miRNA) Therapeutics, Long Non-Coding RNA (lncRNA) Therapeutics, Ribonucleic Acid (RNA) Editing Therapies, Ribozymes

Which Trends Are Influencing The Nucleic Acid Therapeutics Market?

Companies active in the nucleic acid therapeutics market are concentrating on creating novel solutions like antisense oligonucleotide therapy. These therapies aim to target and deactivate particular genes responsible for diseases, providing precise treatment avenues for genetic conditions and uncommon illnesses. Antisense oligonucleotide therapy operates as a precise medical approach, utilizing brief, artificial segments of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) to either inhibit or alter the manifestation of specific genes implicated in disease processes. An example of this is the U.S. Food and Drug Administration (FDA) approval received by Ionis Pharmaceuticals Inc., a US-based biotechnology firm, in December 2024. Their product, TRYNGOLZ (olezarsen), was approved as an adjunctive treatment with diet to reduce triglyceride levels in adults suffering from familial chylomicronemia syndrome (FCS), a rare genetic condition marked by severe hypertriglyceridemia (sHTG) and an elevated likelihood of acute pancreatitis (AP). This marks the inaugural FDA-endorsed therapy capable of providing substantial and lasting triglyceride reduction for this patient group, coupled with a clinically significant reduction in AP incidence when used in conjunction with a low-fat diet. The treatment is designed for ease of use, allowing patients to self-administer it once a month using an auto-injector.

Who Are The Primary Competitors In The Nucleic Acid Therapeutics Market?

Major companies operating in the nucleic acid therapeutics market are Pfizer Inc., Novartis AG, Moderna Inc., BioNTech SE, Alnylam Pharmaceuticals Inc., Sarepta Therapeutics Inc., Arrowhead Pharmaceuticals Inc., Arcturus Therapeutics Holdings Inc., CureVac SE, Sangamo Therapeutics Inc., Beam Therapeutics Inc., Arbutus Biopharma Corporation, Silence Therapeutics plc, Copernicus Therapeutics Inc.

Read the full nucleic acid therapeutics market report here:

https://www.thebusinessresearchcompany.com/report/nucleic-acid-therapeutics-global-market-report

Which Regions Are Expected To Experience Rapid Expansion In The Nucleic Acid Therapeutics Market?

North America was the largest region in the nucleic acid therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nucleic acid therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Nucleic Acid Therapeutics Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27368&type=smp

Browse Through More Reports Similar to the Global Nucleic Acid Therapeutics Market 2026, By The Business Research Company

Sandwich Panels Market Report 2026

https://www.thebusinessresearchcompany.com/report/sandwich-panels-global-market-report

Structural Insulated Panels Market 2026

https://www.thebusinessresearchcompany.com/report/structural-insulated-panels-market

Metal Structural Insulation Panels Market Report 2026

https://www.thebusinessresearchcompany.com/report/metal-structural-insulation-panels-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795